The Obama Administration anticipates releasing the President’s FY17 budget on February 9, 2016. While all the details are not yet known, the FY17 proposal will likely include $755 million for the Cancer Moonshot. We also expect funding for combating public health threats and to support continued research in key areas of focus. Throughout February, Members of Congress will weigh in with the House and Senate Appropriations Committees detailing their requests for FY17 funding levels. Advocates are also able to weigh in to the Committees with testimony. All of these requests help inform the work of the appropriators who determine levels of funding for all federal agencies and programs.
The Senate HELP Committee is advancing individual pieces of legislation as a companion process to the House 21st Century Cures Act (HR 6). Over the next few months, the Senate will consider multiple bills focusing on a variety of topics ranging from health IT to neurodegenerative diseases like multiple sclerosis to disease registries and beyond. While none of the bills currently slated for consideration include mandatory NIH and FDA funding, such funding may be considered later in the Senate process or during bicameral “conference” negotiations before final legislation is sent to the president for signature. Advocates are continuing to urge the inclusion of NIH and FDA resources needed to realize the goals underlying the House and Senate initiatives.